12/6
08:06 am
igms
IGM Biosciences, Inc. (NASDAQ: IGMS) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $21.00 price target on the stock.
Medium
Report
IGM Biosciences, Inc. (NASDAQ: IGMS) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $21.00 price target on the stock.
12/6
05:50 am
igms
Rating for IGMS
Medium
Report
Rating for IGMS
12/6
05:50 am
igms
Rating for IGMS
Medium
Report
Rating for IGMS
12/5
04:09 pm
igms
IGM Biosciences initiated with an Outperform at BMO Capital
Medium
Report
IGM Biosciences initiated with an Outperform at BMO Capital
12/5
04:09 pm
igms
IGM Biosciences initiated with an Outperform at BMO Capital
Medium
Report
IGM Biosciences initiated with an Outperform at BMO Capital
11/11
11:18 am
igms
Rating for IGMS
Medium
Report
Rating for IGMS
10/18
08:26 am
igms
Rating for IGMS
Low
Report
Rating for IGMS
10/18
08:26 am
igms
Rating for IGMS
Low
Report
Rating for IGMS